Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy

doi:10.3748/wjg.v9.i5.951

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1889)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

319

HTML

1467

Figures (1-6)

103

Sum=1889

May 15, 2003 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. May 15, 2003; 9(5): 951-955
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.951

Full Size Figure Download Figure

Figure 4 Cytokines levels in serum after various treatment in the tumor-bearing model. ^-x±s, n = 10, ^bP < 0.01 for the group treated with NIH3T3-mIL-12 cells capsule versus other three counterpart groups, respectively.

Citation: Zheng S, Xiao ZX, Pan YL, Han MY, Dong Q. Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy. World J Gastroenterol 2003; 9(5): 951-955
URL: https://www.wjgnet.com/1007-9327/full/v9/i5/951.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i5.951